Drugs Made In America Acquisition II Corp. (DMII)

Profile

Drugs Made In America Acquisition II Corp. is a blank check company focused on identifying and completing a business combination with one or more businesses in the pharmaceutical sector. As a special purpose acquisition company, it does not operate a traditional commercial business and instead serves as a vehicle for mergers, share exchanges, asset acquisitions, share purchases, recapitalizations, reorganizations, or similar transactions. The company’s stated focus includes evaluating targets connected to pharmaceuticals and related healthcare activities, with an emphasis on domestic drug manufacturing and supply-chain resilience. Incorporated in 2024 and headquartered in New York, Drugs Made In America Acquisition II Corp. plays a market role as a capital-raising and acquisition platform for private operating companies seeking access to public markets.